Cargando…
Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
Many enzymes require post-translational modifications or cofactor machinery for primary function. As these catalytically essential moieties are highly regulated, they act as dual sensors and chemical handles for context-dependent metabolic activity. Clostridioides difficile is a major nosocomial pat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908766/ https://www.ncbi.nlm.nih.gov/pubmed/36778002 http://dx.doi.org/10.3389/fphar.2023.1074619 |
_version_ | 1784884434912149504 |
---|---|
author | Bustin, Katelyn A. Abbas, Arwa Wang, Xie Abt, Michael C. Zackular, Joseph P. Matthews, Megan L. |
author_facet | Bustin, Katelyn A. Abbas, Arwa Wang, Xie Abt, Michael C. Zackular, Joseph P. Matthews, Megan L. |
author_sort | Bustin, Katelyn A. |
collection | PubMed |
description | Many enzymes require post-translational modifications or cofactor machinery for primary function. As these catalytically essential moieties are highly regulated, they act as dual sensors and chemical handles for context-dependent metabolic activity. Clostridioides difficile is a major nosocomial pathogen that infects the colon. Energy generating metabolism, particularly through amino acid Stickland fermentation, is central to colonization and persistence of this pathogen during infection. Here using activity-based protein profiling (ABPP), we revealed Stickland enzyme activity is a biomarker for C. difficile infection (CDI) and annotated two such cofactor-dependent Stickland reductases. We structurally characterized the cysteine-derived pyruvoyl cofactors of D-proline and glycine reductase in C. difficile cultures and showed through cofactor monitoring that their activity is regulated by their respective amino acid substrates. Proline reductase was consistently active in toxigenic C. difficile, confirming the enzyme to be a major metabolic driver of CDI. Further, activity-based hydrazine probes were shown to be active site-directed inhibitors of proline reductase. As such, this enzyme activity, via its druggable cofactor modality, is a promising therapeutic target that could allow for the repopulation of bacteria that compete with C. difficile for proline and therefore restore colonization resistance against C. difficile in the gut. |
format | Online Article Text |
id | pubmed-9908766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99087662023-02-10 Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes Bustin, Katelyn A. Abbas, Arwa Wang, Xie Abt, Michael C. Zackular, Joseph P. Matthews, Megan L. Front Pharmacol Pharmacology Many enzymes require post-translational modifications or cofactor machinery for primary function. As these catalytically essential moieties are highly regulated, they act as dual sensors and chemical handles for context-dependent metabolic activity. Clostridioides difficile is a major nosocomial pathogen that infects the colon. Energy generating metabolism, particularly through amino acid Stickland fermentation, is central to colonization and persistence of this pathogen during infection. Here using activity-based protein profiling (ABPP), we revealed Stickland enzyme activity is a biomarker for C. difficile infection (CDI) and annotated two such cofactor-dependent Stickland reductases. We structurally characterized the cysteine-derived pyruvoyl cofactors of D-proline and glycine reductase in C. difficile cultures and showed through cofactor monitoring that their activity is regulated by their respective amino acid substrates. Proline reductase was consistently active in toxigenic C. difficile, confirming the enzyme to be a major metabolic driver of CDI. Further, activity-based hydrazine probes were shown to be active site-directed inhibitors of proline reductase. As such, this enzyme activity, via its druggable cofactor modality, is a promising therapeutic target that could allow for the repopulation of bacteria that compete with C. difficile for proline and therefore restore colonization resistance against C. difficile in the gut. Frontiers Media S.A. 2023-01-26 /pmc/articles/PMC9908766/ /pubmed/36778002 http://dx.doi.org/10.3389/fphar.2023.1074619 Text en Copyright © 2023 Bustin, Abbas, Wang, Abt, Zackular and Matthews. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Bustin, Katelyn A. Abbas, Arwa Wang, Xie Abt, Michael C. Zackular, Joseph P. Matthews, Megan L. Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes |
title | Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes |
title_full | Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes |
title_fullStr | Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes |
title_full_unstemmed | Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes |
title_short | Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes |
title_sort | characterizing metabolic drivers of clostridioides difficile infection with activity-based hydrazine probes |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908766/ https://www.ncbi.nlm.nih.gov/pubmed/36778002 http://dx.doi.org/10.3389/fphar.2023.1074619 |
work_keys_str_mv | AT bustinkatelyna characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes AT abbasarwa characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes AT wangxie characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes AT abtmichaelc characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes AT zackularjosephp characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes AT matthewsmeganl characterizingmetabolicdriversofclostridioidesdifficileinfectionwithactivitybasedhydrazineprobes |